START
Return
Access
Monitoring the elimination of viral hepatitis as a public health threat among people who inject drugs in Europe
EMCDDA. European Monitoring Centre for Drugs and Drug Addiction
This technical report focuses on an elimination barometer for viral hepatitis to help countries assess progress towards eliminating hepatitis C and B among people who inject drugs (PWID). The barometer is being developed by the EMCDDA together with its expert network on drug-related infectious diseases (DRID), as a follow-up to the first global health sector strategy on viral hepatitis endorsed by the World Health Assembly in 2016. The elimination barometer includes five building blocks (context and needs, inputs, prevention, testing and linkage to care, and impact) and 17 indicators covering the EU, Norway and Turkey.
The European Commission is preparing a third phase of this programme, therefore COPOLAD will be back at the beginning of 2021.